BioSyntech Inc BSYI:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 08/10/23 EDT
0.00UNCH (UNCH)
52 week range
0.00 - 0.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date08/10/23
  • 52 Week Low0.00
  • 52 Week Low Date08/10/23

Key Stats

  • Market Cap116.441
  • Shares Out116.44M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta0.44
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date08/10/23
  • 52 Week Low0.00
  • 52 Week Low Date08/10/23
  • Market Cap116.441
  • Shares Out116.44M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta0.44
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-4.558M
  • ROE (TTM)-
  • Revenue (TTM)147,459.999
  • Gross Margin (TTM)65.93%
  • Net Margin (TTM)-6,302.46%
  • Debt To Equity (MRQ)-128.10%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BioSyntech Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
BioSyntech, Inc. is a Canada-based biotechnology company. The Company is developing biotherapeutic thermogels for regenerative medicine (tissue repair) and therapeutic delivery. The Company's platform technology is a family of hydrogels called BST-Gel, some of which are liquid at low temperature and solid at human body temperature. These gels can be injected or applied to a specific local site and offers properties for the local repair of damaged tissue such as cartilage...
Jeanne Bertonis
Chief Executive Officer
Catherine Auld
Chief Financial Officer
Address
475 Armand-Frappier Blvd.
Laval, QC
H7V 4B3
Canada